Standard BioTools Inc. (LAB)

NASDAQ: LAB · Real-Time Price · USD

0.6290

-0.0294 (-4.47%)

At close: Oct 16, 2026, 4:00 PM EDT

0.6557

+0.0267 (4.24%)

After-hours: Oct 16, 2026, 7:56 PM EDT

Standard BioTools Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	84.6	85.33	91.01	106.34	97.95	130.58
Revenue Growth	-4.78%	-6.24%	-14.42%	8.57%	-24.99%	-5.47%
Gross Profit	42.71	42.54	44.88	50.45	37.05	31.43
Operating Income	-62.64	-93.31	-87.01	-63.04	-99.09	-67.46
Net Income	84.91	-74.9	-184.9	-74.66	-190.1	-59.24
Earnings Per Share	0.22	-0.20	-0.52	-0.94	-2.43	-0.78
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Americas Excl. United States	2.16	2	2.1	2.98	3.68
Emea Excl. Sweden	27.39	26.55	29.82	-	-
Sweden	8.6	9.1	6.38	-	-
United States	28.4	35.4	44.1	41	60.2
Asia-Pacific (Excl. China)	7.88	7.95	7.99	10.06	11.48
China	10.9	10.01	15.95	10.77	12.5
Total	85.33	91.01	106.34	97.95	130.58

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	476.72	187.58	292.87	114.9	165.78	28.45
Total Debt	28.09	30.83	30.7	98.21	102.66	111.65
Net Cash (Debt)	448.63	156.75	262.18	16.69	63.13	-83.2
Net Cash Growth	115.20%	-40.21%	1471.35%	-73.57%	-	-
Net Cash Per Share	1.16	0.41	0.74	0.21	0.81	-1.10

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-80.3	-74.34	-143.45	-43.29	-89.37	-44.06
Capital Expenditures	-2.28	-8.3	-8.36	-2.83	-3.83	-13.26
Free Cash Flow	-82.58	-82.65	-151.81	-46.12	-93.2	-57.33
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	50.48%	49.86%	49.32%	47.44%	37.83%	24.07%
Operating Margin	-74.04%	-109.34%	-95.60%	-59.28%	-101.17%	-51.66%
Pretax Margin	-107.55%	-113.33%	-99.33%	-69.78%	-196.97%	-48.75%
Profit Margin	100.36%	-87.77%	-203.17%	-70.20%	-194.08%	-45.36%
FCF Margin	-97.61%	-96.85%	-166.81%	-43.37%	-95.15%	-43.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	2.92	5.77	7.16	1.65	0.95	2.30